Bravo, Yanauri <br/><br/>
Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension.  [electronic resource] 

 -  American journal of physiology. Renal physiology  Aug 2007 
 - F616-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1931-857X 
<br/><br/><label>Standard No.: </label>10.1152/ajprenal.00507.2006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II--metabolism<br/>Animals<br/>Blood Pressure--drug effects<br/>Body Weight--drug effects<br/>Creatinine--blood<br/>Hypertension--chemically induced<br/>Immunosuppressive Agents--pharmacology<br/>Inflammation--chemically induced<br/>Kidney Diseases--chemically induced<br/>Lead--blood<br/>Lymphocytes--pathology<br/>Macrophages--pathology<br/>Male<br/>Malondialdehyde--urine<br/>Mycophenolic Acid--analogs & derivatives<br/>Oxidative Stress--drug effects<br/>Proteinuria--chemically induced<br/>Rats<br/>Rats, Sprague-Dawley<br/>Superoxides--metabolism<br/>Transcription Factor RelA--metabolism